PŮVODNÍ PRÁCE Amiodarónom indukované tyreopatie | E27 / Vnitř Lék. 2024;70(4):E21-E27 / VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz PROHLÁŠENÍ AUTORŮ: Prohlášení o původnosti: Publikace byla zpracována s využitím uvedené literatury a nebyla publikována ani zaslána k recenznímu řízení do jiného média. Střet zájmů: Žádný. Financování: Ne. Registrace v databázích: N/A Projednání etickou komisí: N/A. LITERATÚRA 1. Dan G, Martinez-Rubio A, Agewall S, et al. Antiarrhythmic drugs-clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Hear. Europace. 2018;20(5):738. doi:10.1093/europace/euy119 2. Petr P, Verener M, Koeleman A. Amiodaron. Prvních čtyricet let. Journal of Applied Biomedicine. 2003:1-20. 3. Júkič T, Punda M, Francechi M, et al. Amiodarone and the thyroid function. Lieči Vjesn. 2015;137:181-188 4. Hrnčiar J. Osobitosti funkčných porúch štítnej žľazy (tyreotoxikóz a hypotyreóz), navodených jódom a jódovými preparátmi, hlavne amiodaronom. V: HRNČIAR, J. a kol.: Endokrinné a hormonálnometabolické choroby ich racionálna diagnostika a komplexná liečba. Centro Median 2000:119-125. ISBN: 80-968358-2-3 5. Robertson RP, Giudice LC, Grossman AB, et al. DeGroot’s Endocrinology: Basic Science and Clinical Practice. Press: Elsevier 2023:1389-1406. ISBN 978-0-323-69412-4. 6. Herendael H, Dorien P. Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia. Vascular Health and Risk Management. 2010;6(1): 465-472. Available from: doi:10.2147/VHRM.S6611 7. Libby P, Bonow RO, Mann DL, et al. Braunwald’s Heart Disease. A Textbook of Cardiovascular Medicine. 12 edition, Press: Elsevier 2021: 2034 p. ISBN 978-0-323-72219-3. 8. Camm AJ, et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. European Heart Journal. 2012;33(21):2719-2747. 9. Cahoon W, Flattery MP, Hess ML. Amiodarone: Development, Clinical Indications and Safety. Progress in Cardiovascular Nursing. 2007;173-176. 10. Rao U, Agarwal A. Amiodarone-induced acute hepatotoxicity. European Journal of Clinical Pharmacology. 2011;68(4):449-450. Dostupné na: doi:10.1007/s00228-011-1126-0. 11. Sloan RW. Cytochrome P-450. New Nomeclature and Clinical Implications. Clin Pharmacol Ther. 1996;61:201 12. Medić F, Bakula M, Alfirević M, et al. Amiodarone and thyroid dysfunction. Acta Clin Croat. 2022;61(2):327-341. doi: 10.20471/acc.2022. 61. 02. 20. 13. Tanda ML, Piantanida E, Lai A, et al. Diagnosis and management of amiodarone- -induced thyrotoxicosis: similarities and differences between North American and European thyroidologists. Clinical Endocrinology. 2008;69(5):812-818. DOI:10.1111/j.13652265.2008.03268.x 14. Tomisti L, Rossi G, Bartalena L, et al. The onset time of amiodarone-induced Thyreotoxicosis (AIT) depends on AIT type. European Journal of Endocrinology. 2014;171:363-368. 15. Bartalena L, Brogioni S, Grasso L, et al. Interleukin-6: A marker of thyroid-destructive processes? Journal of Clinical Endocrinology and Metabolism.1994; 79(5):1424-1427. 16. Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone and thyroid physiology, pathophysiology, diagnosis and management. Trends Cardiovasc Med. 2019;29(5):285295. Dostupné z DOI: 10.1016/j.tcm.2018. 09. 005. 17. Bartalena L,Bogazzi F,Chiovato L, et al. European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid Dysfunction. Eur Thyroid J. 2018 Mar;7(2):55-66. doi: 10.1159/000486957. 18. Podoba J. Eufunkčná struma V: Kreze A, Langer P, Klimeš I et al. Všeobecná a klinická endokrinológia. Academic Electronic Press s.r.o., Bratislava, 2004; s. 219-228. 19. Bogazzi F, Martino E, Dell’Unto E, et al. Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis. Journal of Endocrinological Investigation.2003;26(7):635-640. 20. Shifrin AL, et al. Endocrine Emergencies. Edition 1st. Press: Elselvier 2022. 1-350. ISBN 987-0-323-76097-3. 21. Hudzik B, Zubelewicz -Szkodzinska B. Amiodarone-related thyroid dysfunction. Internal and Emergency Medicin. 2014;9(8):829-839. Dostupné na: doi:10.1007/s11739-014-1140-1. 22. Wanj J, Thang, Zhang R. Evaluation of 99mTc-MIBI in thyroid gland imaging for the diagnosis of amiodarone-induced thyrotoxicosis. Br. J. Radiol 2017 Mar;90(1071):20160836 23. Tsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol. 2009;25(7):421-4. Available from: DOI: 10.1016/s0828-282x(09)70512-4. 24. O’Sullivan AJ, Lewis M, Diamond T. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality. Eur J Endocrinol. 2006;154(4):5336. doi: 10.1530/eje.1.02122. PMID: 16556715. 25. Podoba J, Zajacová H. Amiodaron a poruchy funkcie štítnej žľazy. Cardiology. 2000;9:20-24. 26. Tsang W, Houlden RL. Amiodarone-induced thyrotoxicosis: a review. Can J Cardiol. 2009;25(7):421-4. Dostupné z DOI: 10.1016/s0828-282x(09)70512-4. 27. Jabrocka-Hybel A, Bednarczuk T, Bartalena L, et al. Amiodarone and the thyroid. Endokrynol Pol. 2015;66(2):176-86. doi: 10.5603/EP.2015.0025. 28. Vanderpump MP. Thyroid gland: use of glucocorticoids in amiodarone-induced thyrotoxicosis. Nat Rev Endocrinol. 2009;5(12):650-1. Available from: DOI: 10.1038/nrendo.2009.218. PMID: 19924150. 29. Zhong B, Wnag Y, Zhang G, et al. Environmental Iodine Content, Female Sex and Age Are Associated with New-Onset Amiodarone-Induced Hypothyroidism: A Systematic Review and Meta-Analysis of Adverse Reactions of Amiodarone on the Thyroid. Cardiology. 2016;134(3):366-71. doi: 10.1159/000444578. Epub 2016 Apr 22. 30. Stott DJ, Rodondi N, Kearney PM, et al. Trust Study Group. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism. N Engl J Med. 2017;376(26):2534-2544. Available from: DOI : 10.1056/NEJMoa1603825. 31. Benjamens S, Dullaartr RPF, Sluiter WJ, et al. The clinical value of regular thyroid function tests during amiodarone treatment. Eur J Endocrinol. 2017;177(1):9-14. doi: 10.1530/ EJE-17-0018.
RkJQdWJsaXNoZXIy NDA4Mjc=